BiondVax Pharmaceuticals Ltd.

Historical 13F Holders

Symbol
BVXV
CUSIP
09073Q105
All holders as of
Q3 2022
Type
Equity
Class
SPOND ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 09073Q105 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Sabby Management, LLC 13G
4.9% 1/3/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q3 13 210 k $153 k
2022 Q2 16 334 k $389 k
2022 Q1 20 330 k $544 k
2021 Q4 16 336 k $789 k
2021 Q3 19 255 k $560 k
2021 Q2 18 311 k $891 k
2021 Q1 21 284 k $1.08 M
2020 Q4 15 222 k $623 k
2020 Q3 19 539 k $21.1 M
2020 Q2 16 506 k $11.5 M
2020 Q1 10 405 k $3.12 M
2019 Q4 12 477 k $4.43 M
2019 Q3 9 406 k $2.41 M
2019 Q2 8 406 k $2.34 M
2019 Q1 12 427 k $2.27 M
2018 Q4 11 446 k $2.13 M
2018 Q3 13 451 k $2.53 M
2018 Q2 13 454 k $3.03 M
2018 Q1 16 487 k $2.64 M
2017 Q4 12 497 k $2.61 M
2017 Q3 8 106 k $689 k
2017 Q2 6 28.5 k $164 k
2017 Q1 7 72.8 k $367 k
2016 Q4 3 39.0 k $102 k
2016 Q3 4 32.6 k $119 k
2016 Q2 3 33.4 k $118 k
2016 Q1 4 32.8 k $122 k
2015 Q4 3 32.0 k $126 k
2015 Q3 6 48.2 k $177 k
2015 Q2 6 100 k $495 k